These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21117496)

  • 1. Interactions of nicotine and drugs used in the treatment of mental illnesses with respect to cognitive functions.
    Burda K; Czubak A; Nowakowska E; Kus K; Metelska J; Nowakowska A
    Arzneimittelforschung; 2010; 60(9):527-43. PubMed ID: 21117496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function.
    Cannady R; Weir R; Wee B; Gotschlich E; Kolia N; Lau E; Brotherton J; Levin ED
    Biochem Pharmacol; 2009 Oct; 78(7):788-94. PubMed ID: 19477167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic receptor subtypes and cognitive function.
    Levin ED
    J Neurobiol; 2002 Dec; 53(4):633-40. PubMed ID: 12436426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
    Levin ED; Rezvani AH
    Biochem Pharmacol; 2007 Oct; 74(8):1182-91. PubMed ID: 17714691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A review of the effects of nicotine on schizophrenia].
    Bidzan L
    Psychiatr Pol; 2007; 41(5):737-44. PubMed ID: 18421928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic-antipsychotic drug interactions and cognitive function.
    Levin ED; Rezvani AH
    EXS; 2006; 98():185-205. PubMed ID: 17019889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of and perspectives on psychiatric genomic medicine].
    Mors NP; Børglum AD
    Ugeskr Laeger; 2005 May; 167(20):2191-3. PubMed ID: 15987082
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.
    Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD
    Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action and indications for psychopharmaceutic agents; possibilities and limitations in the elderly].
    Verhoeven WM
    Gerontologie; 1981 Aug; 12(3):126-38. PubMed ID: 6115793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The nicotine receptor as target for the improvement of cognitive symptoms in schizophrenia].
    Quisenaerts C; Morrens M; Sabbe B
    Tijdschr Psychiatr; 2013; 55(6):415-25. PubMed ID: 23864409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.
    Freedman R
    Annu Rev Med; 2014; 65():245-61. PubMed ID: 24111888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1994 Oct; 36(933):89-96. PubMed ID: 7935156
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
    Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
    Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Special characteristics of psychopharmacotherapy of elderly patients].
    Bauer J
    Fortschr Med; 1996 Sep; 114(25):297-302. PubMed ID: 8974977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.